Sai Life Sciences Cash Flow Annual

BSE: 544306 | NSE: SAILIFE | ISIN: INE570L01029 | Sector: Biotechnology & Drugs

1,443.35 +18.90 (1.33%)Updated : 11 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	-94.94	-621.49	-10.94	-124.23
Net Changein Cash	-9.14	79.08	-23.56	-80.25
Cash Taxes Paid	38.93	21.63	13.87	4.08
Net Income/ Starting Line	466.19	227.70	109.23	16.41
Changesin Working Capital	-112.72	-152.72	-52.11	30.85
Cashfrom Operating Activities	509.13	314.04	263.09	219.40
Cash Interest Paid	33.99	77.41	85.33	78.50
Cashfrom Financing Activities	-123.68	301.43	-95.30	-200.65
Issuance( Retirement)of Stock Net	25.09	1,011.64	0.97	2.09
Depreciation/ Depletion	166.86	138.57	119.44	99.43
Other Investing Cash Flow Items Total	197.55	-167.39	-10.69	11.29
Capital Expenditures	-592.96	-369.28	-181.69	-113.08
period Type	-	-	-	-
Foreign Exchange Effects	0.82	0.28	1.03	2.78
Non- Cash Items	-11.19	100.49	86.53	72.72
Financing Cash Flow Items	-53.84	-88.73	-85.33	-78.50
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-395.41	-536.67	-192.38	-101.78

*All figures in crores except per share values

Trending Stocks

5,098.20+155.20(3.14%)

1,102.85+20.85(1.93%)

2,024.95+23.05(1.15%)

1,072.00-24.05 (-2.19%)

310.50-4.95 (-1.57%)

Related News